A detailed history of Avion Wealth transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Avion Wealth holds 23 shares of NTLA stock, worth $338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 19 21.05%
Holding current value
$338
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$19.72 - $27.36 $78 - $109
4 Added 21.05%
23 $0
Q2 2024

Jul 26, 2024

BUY
$20.02 - $27.22 $380 - $517
19 New
19 $0
Q3 2023

Oct 20, 2023

BUY
$31.62 - $45.78 $411 - $595
13 New
13 $0

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.12B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.